icon-    folder.gif   Conference Reports for NATAP  
 
  Presented at the 22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL)
Taipei, Taiwan
February 16-19, 2012
Back grey_arrow_rt.gif
 
 
 
SAFETY AND EFFICACY OF PEGINTERFERON LAMBDA-1a (LAMBDA) COMPARED WITH PEGINTERFERON ALFA-2a (ALFA-2a) IN HCV-INFECTED PATIENTS (G1/2/3) WITH COMPENSATED CIRRHOSIS: EMERGE PHASE 2b EFFICACY AND SAFETY RESULTS THROUGH WEEK 12
 
 
  Reported by Jules Levin
 
22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL 2012), Taipei International Convention Center, February 16-19, 2012
 
RODRIGUEZ-TORRES M,1 HILLSON J,2 LAWITZ E,3 VARGAS H,4 VIERLING J,5 HORGA A,6 GRAY T,2 XU D,2 LOPEZ-TALAVERA JC,6 1FUNDACION DE INVESTIGACION, SAN JUAN, PUERTO RICO; 2ZYMOGENETICS/BMS, SEATTLE, WA, USA; 3ALAMO MEDICAL RESEARCH, SAN ANTONIO, TX, USA; 4 MAYO CLINIC, PHOENIX, AZ, USA; 5BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX, USA; 6BRISTOL-MYERS SQUIBB, WALLINGFORD, CT, USA

APASL1.gif

APASL2.gif

APASL3.gif

APASL4.gif

APASL5.gif

APASL6.gif

APASL7.gif

APASL8.gif

APASL9.gif

APASL10.gif